Investing.com - Quest Diagnostics (NYSE:DGX) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Quest Diagnostics announced earnings per share of $1.42 on revenue of $1.83B. Analysts polled by Investing.com anticipated EPS of $0.56 on revenue of $1.66B.
Quest Diagnostics shares are up 21% from the beginning of the year , still down 0.05% from its 52 week high of $129.82 set on July 22. They are outperforming the S&P 500 which is up 1.4% from the start of the year.
Quest Diagnostics follows other major Healthcare sector earnings this month
Quest Diagnostics's report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Novartis ADR had beat expectations on Tuesday with second quarter EPS of $1.36 on revenue of $11.35B, compared to forecast for EPS of $1.34 on revenue of $11.9B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar